Impact Biomedical (IBO) Receivables (2023 - 2025)
Impact Biomedical's (IBO) quarterly Receivables came in at $5000.0 in Q4 2025, down 97.51% YoY from $201000.0 in Q4 2024, and down 97.49% on a QoQ basis from $199000.0 in Q3 2025.
Impact Biomedical (IBO) Receivables (2023 - 2025) Analysis & Trends
Impact Biomedical (IBO) has 3 years of Receivables data on file, last reported at $5000.0 in Q4 2025.
- Quarterly Receivables fell 97.51% year-over-year to $5000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $5000.0 (down 97.51% YoY) and the FY2025 annual result came in at $5000.0, down 93.15% from the prior year.
- Receivables eased to $5000.0 in Q4 2025, from $199000.0 in the prior quarter.
- In the past five years, Receivables ranged from a high of $201000.0 in Q4 2024 to a low of $5000.0 in Q4 2025.
- A 3-year average of $148625.0 and a median of $163500.0 in 2023 frame the typical range for Receivables.
- Annual changes were most pronounced in 2024 — Receivables soared 57.03% — and 2025, when it slumped 97.51%.
- Tracing IBO's Receivables over 3 years: stood at $128000.0 in 2023, then soared by 57.03% to $201000.0 in 2024, then tumbled by 97.51% to $5000.0 in 2025.
- The last three Receivables figures came in at $5000.0 (Q4 2025), $199000.0 (Q3 2025), and $200000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 2.13 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 6.57 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1.93 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 160.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 1.06 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 912.74 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 1.09 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 215.33 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Impact Biomedical | 49.54 Mn | 49.53 Mn | 2,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5,000.00 |
| Sep 30, 2025 | 199,000.00 |
| Jun 30, 2025 | 200,000.00 |
| Mar 31, 2025 | 200,000.00 |
| Dec 31, 2024 | 201,000.00 |
| Jun 30, 2024 | 128,000.00 |
| Mar 31, 2024 | 128,000.00 |
| Dec 31, 2023 | 128,000.00 |